Long-Term Dipeptidyl-Peptidase 4 Inhibition Reduces Atherosclerosis and Inflammation via Effects on Monocyte Recruitment and Chemotaxis

Study Questions:

What is the effect of dipeptidyl-peptidase 4 (DPP-4) inhibition on atherosclerosis in mice?